title: Race and asthma control in the pediatric population of Hawaii.
abstract: OBJECTIVE
  The racially unique population of Hawaii has one of the highest prevalences of childhood asthma in America. We estimate the prevalence of impaired asthma control among asthmatic children in Hawaii and determine which factors are associated with impaired control.
  
  
  METHODS
  We analyzed data from 477 asthmatic children living in Hawaii participating in the 2006-2008 Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-Back Surveys. Impaired asthma control was modeled after 2007 National Asthma Education and Prevention Program guidelines. Univariate and multivariate analyses were used to identify factors associated with impaired asthma control.
  
  
  RESULTS
  Children (53.8%) with asthma were either part or full Native Hawaiian/Pacific Islander. While 35.6% of asthmatic children met criteria for impaired asthma control, being part or full Native Hawaiian/Pacific Islander was not associated with impaired control. Only 31.1% of children with impaired control reported the use of inhaled corticosteroids despite >80% having had a routine checkup for asthma in the past year and receipt of asthma education from a healthcare provider.
  
  
  CONCLUSIONS
  A large proportion of asthmatic children in Hawaii have impaired asthma control that does not appear to be associated with race but may be associated with inadequate pharmacologic therapy. While a significant percentage reported receiving routine asthma care and asthma education, a minority reported using inhaled corticosteroids. Reasons for this discrepancy between asthma assessment and treatment are unclear. However, additional education on part of the physician, community, and healthcare system are likely to improve management and reduce morbidity in this population.
authors.affiliation: Division of Pediatric Pulmonary Medicine, Department of Pediatrics, University of California San Francisco, California. wupedspulm@gmail.com.
authors.forename: Brian H
authors.initials: BH
authors.lastname: Wu
authors.forename: Michael D
authors.initials: MD
authors.lastname: Cabana
authors.forename: Joan F
authors.initials: JF
authors.lastname: Hilton
authors.forename: Ngoc P
authors.initials: NP
authors.lastname: Ly
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000453:epidemiology* / Q000208:ethnology*; D040343:Behavioral Risk Factor Surveillance System; D002648:Child; D002675:Child, Preschool; D005260:Female; D006254:Hawaii; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009017:Morbidity; D015995:Prevalence; D044469:Racial Groups
chemical_list: D000305:Adrenal Cortex Hormones